Canopy Growth (CGC) | Stock Overview & Key Data

Canopy Growth Corporation | Healthcare

US$1.66

23.88%

| Compare Stocks:

Canopy Growth vs Zoetis Canopy Growth vs Haleon Plc - ADR Canopy Growth vs Aquestive Canopy Growth vs Anika Therapeutics Canopy Growth vs Organigram Holdings Canopy Growth vs S&P 500 | Market

Canopy Growth Performance Comparison

Loading chart data...

Canopy Growth

Healthcare Sector

S&P 500

View Full Price History

Stock Range

Today's Range

Low: US$1.34 High: US$1.66

on May 16, 2025

52 Week Range

Low: US$0.77 High: US$11.95

on April 9, 2025

on May 16, 2024

All-Time High: US$592.50 on October 15, 2018

Key Statistics

Market Cap i $299.4M

EPS i -3.62

P/E Ratio (TTM) i -0.19

Forward P/E i -2.16

P/B Ratio i 0.36

PEG Ratio i -2.16

Div. Yield i 0.00%

ROE i -84.02%

Beta i 2.210

Debt to Equity i 82.79

Financial Highlights

Profitability

Gross Margin i 32.23%

Operating Margin i -26.08%

Profit Margin i -169.71%

Returns and Earnings

Return on Assets (TTM) i -4.63%

Return on Equity (TTM) i -84.02%

EBITDA i $-36.2M

Net Income (TTM) i $-341.8M

Growth

Revenue (TTM) i

Revenue Per Share (TTM) i

Quarterly Revenue Growth i

Quarterly Earnings Growth i N/A

Peer Performance Comparison

Company	Market Cap	1W	1M	3M	6M	YTD	1Y	3Y	5Y
Canopy Growth CGC	299.40M Small-cap	26.72%	40.68%	-2.92%	-56.20%	-42.36%	-84.70%	-96.99%	-99.15%
Zoetis ZTS	71.39B Large-cap	2.37%	11.09%	4.19%	-7.58%	0.26%	-6.33%	0.30%	25.31%
Haleon Plc - ADR HLN	48.65B Large-cap	0.56%	6.30%	8.11%	14.53%	14.41%	22.91%	41.16%	41.16%
Aquestive AQST	236.40M Micro-cap	-14.70%	-4.80%	-24.44%	-48.71%	-35.15%	-23.47%	126.67%	-58.61%
Anika Therapeutics ANIK	174.82M Micro-cap	4.73%	-9.50%	-31.32%	-28.46%	-24.80%	-52.01%	-41.90%	-63.47%
Organigram Holdings OGI	165.89M Micro-cap	15.25%	30.77%	0.00%	-8.11%	-18.07%	-32.67%	-71.90%	-79.39%

Ownership & Short Interest

Insider Ownership i 0.12%

Institutional Ownership i 8.33%

Shares Short i 16M

Short Ratio i 2.08

Short % of Shares Outstanding i 12.04%

Average 10-Day Volume i 5M

Average 90-Day Volume i 7M

Canopy Growth Recurring Investment / Dollar-Cost Averaging Calculator

Calculate how a regular investment in Canopy Growth would have performed over time.

Investment Amount

Investment Frequency

Start Date

End Date (Optional)

If not specified, the latest available data will be used

Reinvest Dividends

Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.

Frequently Asked Questions

What is CGC's 52-week high and low?

In the last 52 weeks, Canopy Growth reached a high of US$11.95 (on May 16, 2024) and a low of US$0.77 (on April 9, 2025).

What is the market cap and P/E ratio for CGC?

Curious about Canopy Growth's size and valuation? Its market capitalization stands at 299.40M. When it comes to valuation, the P/E ratio (trailing twelve months) is -0.19, and the forward P/E (looking ahead) is -2.16.

Does CGC pay dividends? If so, what's the yield?

As for dividends, Canopy Growth isn't currently offering a significant yield, or that specific data isn't available right now. Its payout ratio, which shows how much of its earnings are paid as dividends, is 0.00%.

Who are Canopy Growth's main competitors or similar companies to consider before investing?

When looking at Canopy Growth, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:

Company	Mkt Cap	Sector	Industry	1Y Return	3Y Return
Zoetis ZTS	71.39B	Healthcare	Drug Manufacturers - Specialty & Generic	-6.33%	0.30%
Haleon Plc - ADR HLN	48.65B	Healthcare	Drug Manufacturers - Specialty & Generic	22.91%	41.16%
Aquestive AQST	236.40M	Healthcare	Drug Manufacturers - Specialty & Generic	-23.47%	126.67%
Anika Therapeutics ANIK	174.82M	Healthcare	Drug Manufacturers - Specialty & Generic	-52.01%	-41.90%
Organigram Holdings OGI	165.89M	Healthcare	Drug Manufacturers - Specialty & Generic	-32.67%	-71.90%

For a more comprehensive list, please see the Peer Performance Comparison table on this page.

What are the key financial health indicators for Canopy Growth Corporation? (e.g., ROE, Debt/Equity)

To get a sense of Canopy Growth's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -84.02%, the Debt to Equity ratio from the most recent quarter is 82.79, and its Gross Profit Margin stands at 32.23%.

What is the recent revenue and earnings growth for CGC?

Looking at Canopy Growth's growth, its revenue over the trailing twelve months (TTM) was $198M. Compared to the same quarter last year (YoY), quarterly revenue grew by -4.80%, and quarterly earnings saw a YoY growth of N/A.

How much of CGC stock is held by insiders and institutions?

Wondering who owns Canopy Growth stock? Company insiders (like executives and directors) hold about 0.12% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 8.33%.

For more common questions about our data, please visit our About Data page.

Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.